-
ANH News Beat (week 36/2023)
06 September 2023
Our weekly roundup of the latest natural and covid news in one place. Read the headlines or click on the links to find out more
-
What's driving turbo cancers and autoimmune flare-ups?
23 August 2023
Vaccinologist Geert Vanden Bossche DVM PhD explains the possible mechanism for the widely reported spikes in aggressive cancers and autoimmune flares. Introduced by Rob Verkerk PhD
-
ANH-USA study finds 'forever chemicals' in kale
28 June 2023
Our US team at Alliance for Natural Health USA tested the US FDA's claim that the majority of the US food supply was free from PFAS 'forever chemicals' - and guess what we found?
News / Food4Health Campaign / Health / Food / Activism
-
ANH News Beat (week 24/2023)
15 June 2023
Our weekly roundup of the latest natural and covid news in one place. Read the headlines or click on the links to find out more
-
The new dawn of mRNA technology
11 May 2023
Republishing article by Rob Verkerk PhD for Dr Ron Hoffman's Intelligent Medicine: Cancer patients look to be next in line for experimental mRNA shots
News / ANH Covid Zone / Health / Campaigns
-
PFAS campaign airs Down Under
20 July 2023
ANH founder, Rob Verkerk PhD joined Australian TNT Radio presenter, Dean Mackin, to discuss ANH-USA's PFAS in kale report and why PFAS chemicals pose such a serious threat to humanity and the environment
-
ANH News Beat (week 15/2023)
13 April 2023
Our weekly roundup of the latest natural and covid news in one place. Read the headlines or click on the links to find out more
-
ANH News Beat (week 8/2023)
23 February 2023
Our weekly roundup of the latest natural and covid news in one place. Read the headlines or click on the links to find out more
-
Peptide bioregulators presentation
18 July 2023
This presentation on peptide bioregulators is available to all Pathfinder members with an interest in their mechanisms and how they might help support our overall health
-
Pathfinder Members' Briefing and Q&A - June 2023
20 June 2023
Zoom recording of our Pathfinder members' briefing and Q&A for June 2023